Author:
Bolton W K,Scheld W M,Spyker D A,Overby T L,Sande M A
Abstract
We have examined the pharmacokinetics of moxalactam (LY127935) in 36 subjects with various degrees of renal dysfunction. Creatinine clearance (Ccr)/1.73 m2 ranged from zero to 135.8 ml/min. After a 1-g administration of moxalactam intravenously, the volume of distribution was 20.6 /+- 9.5 liters (0.28 liter/kg), and the mean half-life ranged from 3.1 h for subjects with Ccr greater than 65 ml/min to 19.3 h for subjects with Ccr less than 10 ml/min. The moxalactam clearance was closely correlated to Ccr (r = 0.93, P less than 0.0001) and excretion of antibiotic was 73.6 +/- 13% in normal subjects. Renal clearance accounted for 90% of moxalactam clearance in the normal subjects. A dosage schedule for administering moxalactam to patients with various degrees of renal dysfunction is provided.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference18 articles.
1. In vitro activity of LY127935;Barza M.;Antimicrob. Agents Chemother.,1979
2. Pharmacokinetics of cefazolin in patients with renal failure: special reference to hemodialysis;Brogard J. M.;J. Clin. Pharmacol.,1977
3. Pharmacology of cefazolin and other cephalosporins in patients with renal insufficiency;Craig W. A.;J. Infect. Dis. (Suppl.)128:S347-S353.,1973
4. Diem K. and C. Lentner. 1970. Scientific tables p. 711. In Documenta Geigy 7th ed. J. R. Geigy Basel.
5. In vitro activity of LY127935;Fass R. J.;Antimicrob. Agents Chemother.,1979
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献